Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells

被引：0
|
作者：
Xing-dong Xu
Lan Yang
Li-yun Zheng
Yan-yan Pan
Zhi-fei Cao
Zhi-qing Zhang
Quan-sheng Zhou
Bo Yang
Cong Cao
机构：
[1] the Third Hospital affiliated to Soochow University,Department of General Surgery
[2] the First Affiliated Hospital of Soochow University,Department of Neurology
[3] Cyrus Tang Hematology Center,undefined
[4] Soochow University,undefined
[5] Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and Institute of Neuroscience,undefined
[6] Soochow University,undefined
来源：
BMC Cancer | / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)
    Almenara, J
    Rosato, R
    Grant, S
    LEUKEMIA, 2002, 16 (07) : 1331 - 1343
  • [32] The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis
    Q-L Zhang
    L Wang
    Y-W Zhang
    X-X Jiang
    F Yang
    W-L Wu
    A Janin
    Z Chen
    Z-X Shen
    S-J Chen
    W-L Zhao
    Leukemia, 2009, 23 : 1507 - 1514
  • [33] The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis
    Zhang, Q-L
    Wang, L.
    Zhang, Y-W
    Jiang, X-X
    Yang, F.
    Wu, W-L
    Janin, A.
    Chen, Z.
    Shen, Z-X
    Chen, S-J
    Zhao, W-L
    LEUKEMIA, 2009, 23 (08) : 1507 - 1514
  • [34] Growth inhibition of renal cancer cells by histone deacetylase inhibitors, suberoylanilide hydroxamic acid (SAHA) and PXD101
    Min, Gyeong Eun
    Hwang, Jung Jin
    Yoo, Changhee
    Kim, Mi-Joung
    Kim, Yong-Sook
    Song, Kanghyon
    Kim, Seong Cheol
    Kwon, Taek Min
    Park, Jong Yeon
    Ahn, Tai Young
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2008, 179 (04): : 40 - 40
  • [35] Autophagy-related genes are induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid via the activation of cathepsin B in human breast cancer cells
    Han, Han
    Li, Jing
    Feng, Xiuyan
    Zhou, Hui
    Guo, Shanchun
    Zhou, Weiqiang
    ONCOTARGET, 2017, 8 (32) : 53352 - 53365
  • [36] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, selectively induces growth suppression and cell death of endometrial stromal sarcoma cells in vitro
    Hrzenjak, Andelko
    Moinfar, Farid
    Kremser, Marie-Luise
    Strohmeier, Bettina
    Zatloukal, Kurt
    Denk, Helmut
    VIRCHOWS ARCHIV, 2007, 451 (02) : 401 - 401
  • [37] A proteomic view of the effects of histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on prostate cancer cell line PC3
    Hong, L. T. T.
    Scharf, C.
    Hammer, E.
    Sonnemann, J.
    Beck, J. F.
    Voelker, U.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S365 - S365
  • [38] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer
    Shi, Yi-kang
    Li, Zhong-hua
    Han, Xi-qian
    Yi, Ji-hu
    Wang, Zhen-hua
    Hou, Jing-li
    Feng, Cong-ran
    Fang, Qing-hong
    Wang, Hui-hui
    Zhang, Peng-fei
    Wang, Feng-shan
    Shen, Jie
    Wang, Peng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (06) : 1131 - 1140
  • [39] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer
    Yi-kang Shi
    Zhong-hua Li
    Xi-qian Han
    Ji-hu Yi
    Zhen-hua Wang
    Jing-li Hou
    Cong-ran Feng
    Qing-hong Fang
    Hui-hui Wang
    Peng-fei Zhang
    Feng-shan Wang
    Jie Shen
    Peng Wang
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 1131 - 1140
  • [40] Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza™, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer
    George R. Blumenschein
    Merrill S. Kies
    Vassiliki A. Papadimitrakopoulou
    Charles Lu
    Ashok J. Kumar
    Justin L. Ricker
    Judy H. Chiao
    Cong Chen
    Stanley R. Frankel
    Investigational New Drugs, 2008, 26 : 81 - 87
12345